NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 13.0% on 5/14/24. The shares closed at $20.32. Moreover, trading volume in this advance was unusually high at 199% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 30.7% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, NVCR is expected to continue to be Value Creation neutral.
NovoCure has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. NovoCure has a poor Power Rating of 28 and a very low Appreciation Score of 8, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment